Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jupiter Neurosciences (JUNS) Liabilities and Shareholders Equity (2024 - 2025)

Jupiter Neurosciences (JUNS) has disclosed Liabilities and Shareholders Equity for 2 consecutive years, with $5.6 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 10.29% to $5.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.1 million through Dec 2025, up 171.49% year-over-year, with the annual reading at $5.6 million for FY2025, 10.29% down from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $5.6 million at Jupiter Neurosciences, up from $2.6 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $6.2 million in Q4 2024, with the low at $85546.0 in Q3 2024.